Related references
Note: Only part of the references are listed.Conformational polymorphism on imatinib mesylate: Grinding effects
Damian Grillo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Reduction of imatinib absorption after gastric bypass surgery
Hongtao Liu et al.
LEUKEMIA & LYMPHOMA (2011)
Response to the case report by Mattar: Generic Imatinib (Imatib, Cipla) in a patient with chronic myeloid leukemia in chronic phase
Jaideep Gogtay et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Failure of copy Imatib (CIPLA, India) to maintain hematologic and cytogenetic responses in chronic myeloid leukemia in chronic phase
Mervat Mattar
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Hematologic and Molecular Responses to Generic Imatinib in Patients With Chronic Myeloid Leukemia
Farnaz Razmkhah et al.
LABMEDICINE (2010)
Hematologic Relapse after 2 Years on a Non-Authorized Copy Version of Imatinib in a Patient with Chronic Myeloid Leukemia in Chronic Phase: A Case Report
Zoubir Chouffai
CASE REPORTS IN ONCOLOGY (2010)
Effect of a proton pump inhibitor on the pharmacokinetics of imatinib
Merrill J. Egorin et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Effect of antacid on imatinib absorption
Brian A. Sparano et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Bioequivalence of Two Film-Coated Tablets of Imatinib Mesylate 400 mg: A Randomized, Open-Label, Single-Dose, Fasting, Two-Period, Two-Sequence Crossover Comparison in Healthy Male South American Volunteers
Susana Parrillo-Campiglia et al.
CLINICAL THERAPEUTICS (2009)
Administration of imatinib mesylate in patients with chronic myeloid leukemia with short bowel
Rie Yamazaki et al.
LEUKEMIA & LYMPHOMA (2009)
Imatinib Mesylate Pharmacokinetics Before and After Sleeve Gastrectomy in a Morbidly Obese Patient with Chronic Myeloid Leukemia
Carolina Pavlovsky et al.
PHARMACOTHERAPY (2009)
Clinical pharmacokinetics of imatinib
B Peng et al.
CLINICAL PHARMACOKINETICS (2005)
Share Paper
